Anticancer drug targets: growth factors and growth factor signaling

被引：121

作者：

Gibbs, JB ^{[1
]}

机构：

[1] Merck Sharp & Dohme Ltd, Dept Canc Res, Wp16 101 Canc Res, West Point, PA 19486 USA

来源：

关键词：

D O I：

10.1172/JCI9084

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：9 / 13

页数：5

共 34 条

[1] [Anonymous], 1997, BIOCH BIOPHYSICA ACT
[2] Baselga J, 1999, SEMIN ONCOL, V26, P78
[3] Baselga J, 1998, CANCER RES, V58, P2825
[4] Du W, 1999, CANCER RES, V59, P4208
[5] Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors
Eckhardt, SG
Rizzo, J
Sweeney, KR
Cropp, G
Baker, SD
Kraynak, MA
Kuhn, JG
Villalona-Calero, MA
Hammond, L
Weiss, G
Thurman, A
Smith, L
Drengler, R
Eckardt, JR
Moczygemba, J
Hannah, AL
Von Hoff, DD
Rowinsky, EK
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1095 - 1104
[6] Ewer MS, 1999, SEMIN ONCOL, V26, P96
[7] Fan Zhen, 1998, Current Opinion in Oncology, V10, P67, DOI 10.1097/00001622-199801000-00011
[8] Identification of a novel inhibitor of mitogen-activated protein kinase kinase
Favata, MF
Horiuchi, KY
Manos, EJ
Daulerio, AJ
Stradley, DA
Feeser, WS
Van Dyk, DE
Pitts, WJ
Earl, RA
Hobbs, F
Copeland, RA
Magolda, RL
Scherle, PA
Trzaskos, JM
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 18623 - 18632
[9] Promising new developments in cancer chemotherapy
Ferrante, K
Winograd, B
Canetta, R
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (Suppl 1) : S61 - S68
[10] Analogs of staurosporine: Potential anticancer drugs?
Gescher, A
[J]. GENERAL PHARMACOLOGY, 1998, 31 (05): : 721 - 728